{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:44:24Z","timestamp":1793979864053,"version":"4.8.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T00:00:00Z","timestamp":1707955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T00:00:00Z","timestamp":1707955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Sam's research foundation","award":["RNAG448"],"award-info":[{"award-number":["RNAG448"]}]},{"name":"the Bernard Wolfe Health Neuroscience Fund"},{"name":"Wellcome Trust Investigator Award","award":["Reference No. 206368\/Z\/17\/Z"],"award-info":[{"award-number":["Reference No. 206368\/Z\/17\/Z"]}],"id":[{"id":"https:\/\/ror.org\/029chgv08","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the NIHR Cambridge Biomedical Research Centre","award":["NIHR203312"],"award-info":[{"award-number":["NIHR203312"]}],"id":[{"id":"https:\/\/ror.org\/05m8dr349","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the NIHR Applied Research Collaboration East of England","id":[{"id":"https:\/\/ror.org\/03pzxq793","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Prader\u2013Willi syndrome (PWS) is a rare and complex neurodevelopmental disorder resulting from absent paternal expression of maternally imprinted genes at chromosomal locus 15q11-13. This absence of expression occurs as a consequence of a deletion on the chromosome 15 of paternal origin (\n                      <jats:italic>ca.<\/jats:italic>\n                      70%), a chromosome 15 maternal uniparental disomy (mUPD;\n                      <jats:italic>ca.<\/jats:italic>\n                      25%), or an imprinting centre defect (IC;\n                      <jats:italic>ca<\/jats:italic>\n                      . 1\u20133%). At birth, individuals with PWS are severely hypotonic and fail to thrive. Hyperphagia and characteristic physical and neuropsychiatric phenotypes become apparent during childhood. The risk for the development of a co-morbid psychotic illness increases during the teenage years, specifically in those with PWS due to the presence of an mUPD. The primary aim of this literature review is to inform clinical practice. To achieve this, we have undertaken a systematic analysis of the clinical research literature on prevalence, presentation, course, characteristics, diagnosis and treatment of psychotic illness in people with PWS. The secondary aim is to identify clinical aspects of psychotic illness in PWS in need of further investigation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and findings<\/jats:title>\n                    <jats:p>A systematic literature review on psychosis in PWS was conducted on the databases\u00a0Web of Knowledge, PubMed and Scopus, using the terms \u201c((Prader\u2013Willi syndrome) OR (Prader Willi Syndrome)) AND ((psychosis) OR (psychotic illness))\u201d. All articles written in English and reporting original human research were reviewed. In all but three of the 16 cohort studies in which the genetic types were known, the authors reported higher rates of psychosis in people with PWS resulting from an mUPD, compared to those with the deletion subtype of PWS. When psychosis was present the presentation was psychosis similar regardless of genetic type and was usually characterised by an acute onset of hallucinations and delusions accompanied by confusion, anxiety and motor symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The onset of confusion, an affective cyclical pattern with the presence of abnormal mental beliefs and experiences, usually of rapid onset is suggestive of the development of psychotic illness. Phenomenologically, this psychosis in people with PWS is atypical in comparison to schizophrenia and bipolar disorder in the general population. The relationship to psychosis in the general population and the optimum treatments remain uncertain.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-024-03026-y","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T11:02:39Z","timestamp":1707994959000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Psychotic illness in people with Prader\u2013Willi syndrome: a systematic review of clinical presentation, course and phenomenology"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5252-8873","authenticated-orcid":false,"given":"Lucie C. S.","family":"Aman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzannah D.","family":"Lester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C.","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,15]]},"reference":[{"issue":"11","key":"3026_CR1","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1136\/jmg.38.11.792","volume":"38","author":"JE Whittington","year":"2001","unstructured":"Whittington JE, Holland AJ, Webb T, Butler J, Clarke D, Boer H. Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region. J Med Genet. 2001;38(11):792\u20138.","journal-title":"J Med Genet"},{"key":"3026_CR2","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/S2215-0366(18)30009-9","volume":"5","author":"LCS Aman","year":"2018","unstructured":"Aman LCS, Manning KE, Whittington JE, Holland AJ. Mechanistic insights into the genetics of affective psychosis from Prader\u2013Willi syndrome. Lancet Psychiatry. 2018;5:370\u20138.","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"3026_CR3","doi-asserted-by":"publisher","first-page":"104379","DOI":"10.1016\/j.ejmg.2021.104379","volume":"65","author":"SA Bellis","year":"2022","unstructured":"Bellis SA, Kuhn I, Adams S, Mullarkey L, Holland A. The consequences of hyperphagia in people with Prader\u2013Willi syndrome: a systematic review of studies of morbidity and mortality. Eur J Med Genet. 2022;65(1):104379.","journal-title":"Eur J Med Genet"},{"key":"3026_CR4","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1542\/peds.91.2.398","volume":"91","author":"VA Holm","year":"1993","unstructured":"Holm VA, Cassidy SB, Butler MG, Hanchett JM, Greenswag LR, Whitman BY, et al. Prader\u2013Willi syndrome: consensus diagnostic criteria. Pediatrics. 1993;91:398\u2013402.","journal-title":"Pediatrics"},{"issue":"1","key":"3026_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/gim.0b013e31822bead0","volume":"14","author":"SB Cassidy","year":"2012","unstructured":"Cassidy SB, Schwartz S, Miller JL, Driscoll DJ. Prader\u2013Willi syndrome. Genet Med. 2012;14(1):10\u201326.","journal-title":"Genet Med"},{"issue":"1","key":"3026_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s11689-021-09373-2","volume":"13","author":"L Schwartz","year":"2021","unstructured":"Schwartz L, Caix\u00e0s A, Dimitropoulos A, Dykens E, Duis J, Einfeld S, et al. Behavioral features in Prader\u2013Willi syndrome (PWS): consensus paper from the International PWS Clinical Trial Consortium. J Neurodev Disord. 2021;13(1):25. https:\/\/doi.org\/10.1186\/s11689-021-09373-2.","journal-title":"J Neurodev Disord"},{"key":"3026_CR7","first-page":"372","volume":"2021","author":"MJ Page","year":"2021","unstructured":"Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;2021:372.","journal-title":"BMJ"},{"key":"3026_CR8","first-page":"1260","volume":"86","author":"A Prader","year":"1956","unstructured":"Prader A, Labhart AWH. A syndrome of obesity, hyposomia, cryptorchidism, and oligophrenia after a myotonic state in newborn. Swiss Weekly Med J. 1956;86:1260\u20131.","journal-title":"Swiss Weekly Med J"},{"issue":"10","key":"3026_CR9","first-page":"309","volume":"33","author":"H Kollrack","year":"1966","unstructured":"Kollrack H, Wolff D. Paranoid-hallucinatory psychosis in the Prader\u2013Labhart\u2013Willi\u2013Funconi-syndrom. Acta Paedopsychiatr. 1966;33(10):309\u201314.","journal-title":"Acta Paedopsychiatr"},{"issue":"1","key":"3026_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1017\/S0790966700002019","volume":"12","author":"D Clarke","year":"1995","unstructured":"Clarke D, Webb T, Bachmannclarke J. Prader\u2013Willi-syndrome and psychotic symptoms-report of a further case. Ir J Psychol Med. 1995;12(1):27\u20139.","journal-title":"Ir J Psychol Med"},{"key":"3026_CR11","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1192\/bjp.163.5.680","volume":"163","author":"DJ Clarke","year":"1993","unstructured":"Clarke DJ. Prader\u2013Willi syndrome and psychoses. Br J Psychiatry. 1993;163:680\u20134.","journal-title":"Br J Psychiatry"},{"issue":"5","key":"3026_CR12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1159\/000154231","volume":"44","author":"H Ewald","year":"1994","unstructured":"Ewald H, Mors O, Flint T, Kruse TA. Linkage analysis between manic-depressive illness and the region on chromosome 15q involved in Prader\u2013Willi syndrome, including two GABA(A) receptor subtype genes. Hum Hered. 1994;44(5):287\u201394.","journal-title":"Hum Hered"},{"issue":"3","key":"3026_CR13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3109\/13651509709024729","volume":"1","author":"JF Whittaker","year":"1997","unstructured":"Whittaker JF, Cooper C, Harrington RC, Price DA. Prader\u2013Willi syndrome and acute psychosis. Int J Psychiatry Clin Pract. 1997;1(3):217\u20139.","journal-title":"Int J Psychiatry Clin Pract"},{"key":"3026_CR14","first-page":"59","volume":"62","author":"GA Bray","year":"1983","unstructured":"Bray GA, Dahms WT, Swerdloff RS, Fiser RH, Atkinson RL, Carrel RE. The Prader\u2013Willi syndrome: a study of 40 patients and a review of the literature. Medicine (United States). 1983;62:59\u201380.","journal-title":"Medicine (United States)"},{"key":"3026_CR15","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/ajmg.1320280415","volume":"28","author":"BY Whitman","year":"1987","unstructured":"Whitman BY, Accardo P. Emotional symptoms in Prader\u2013Willi syndrome adolescents. J Am Genet Med. 1987;28:897\u2013905.","journal-title":"J Am Genet Med"},{"issue":"Pt 6","key":"3026_CR16","first-page":"463","volume":"42","author":"A Beardsmore","year":"1998","unstructured":"Beardsmore A, Dorman T, Cooper SA, Webb T. Affective psychosis and Prader\u2013Willi syndrome. J Intellect Disabil Res. 1998;42(Pt 6):463\u201371.","journal-title":"J Intellect Disabil Res"},{"issue":"Pt 6","key":"3026_CR17","first-page":"451","volume":"42","author":"D Clarke","year":"1998","unstructured":"Clarke D. Prader\u2013Willi syndrome and psychotic symptoms: 2. A preliminary study of prevalence using the psychopathology assessment schedule for adults with developmental disability checklist. J Intell Disabil Res. 1998;42(Pt 6):451\u20134.","journal-title":"J Intell Disabil Res"},{"issue":"9301","key":"3026_CR18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0140-6736(02)07340-3","volume":"359","author":"H Boer","year":"2002","unstructured":"Boer H, Holland A, Whittington J, Butler J, Webb T, Clarke D. Psychotic illness in people with Prader Willi syndrome due to chromosome 15 maternal uniparental disomy. Lancet. 2002;359(9301):135\u20136.","journal-title":"Lancet"},{"issue":"1","key":"3026_CR19","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1136\/jmg.40.1.72","volume":"40","author":"A Vogels","year":"2003","unstructured":"Vogels A, Matthijs G, Legius E, Devriendt K, Fryns J-P. Chromosome 15 maternal uniparental disomy and psychosis in Prader\u2013Willi syndrome. J Med Genet. 2003;40(1):72\u20133.","journal-title":"J Med Genet"},{"issue":"1","key":"3026_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1034\/j.1601-5215.2003.00006.x","volume":"15","author":"WMA Verhoeven","year":"2003","unstructured":"Verhoeven WMA, Tuinier S, Curfs LMG. Prader\u2013Willi syndrome: cycloid psychosis in a genetic subtype? Acta Neuropsychiatr. 2003a;15(1):32\u20137.","journal-title":"Acta Neuropsychiatr."},{"issue":"1","key":"3026_CR21","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41398-022-02014-9","volume":"12","author":"HM Heseding","year":"2022","unstructured":"Heseding HM, Jahn K, Eberlein CK, Wieting J, Maier HB, Proskynitopoulos PJ, et al. Distinct promoter regions of the oxytocin receptor gene are hypomethylated in Prader\u2013Willi syndrome and in Prader\u2013Willi syndrome associated psychosis. Transl Psychiatry. 2022;12(1):246. https:\/\/doi.org\/10.1038\/s41398-022-02014-9.","journal-title":"Transl Psychiatry"},{"key":"3026_CR22","first-page":"6","volume":"17","author":"C Louveau","year":"2023","unstructured":"Louveau C, Turtuluci MC, Consoli A, Poitou C, Coupaye M, Krebs MO, et al. Prader\u2013Willi syndrome: symptoms and topiramate response in light of genetics. Front Neurosci. 2023;17:6\u201311.","journal-title":"Front Neurosci"},{"key":"3026_CR23","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/cge.13142","volume":"93","author":"AM Manzardo","year":"2018","unstructured":"Manzardo AM, Weisensel N, Ayala S, Hossain W, Butler MG. Prader\u2013Willi syndrome genetic subtypes and clinical neuropsychiatric diagnoses in residential care adults. Clin Genet. 2018;93:622\u201331.","journal-title":"Clin Genet"},{"issue":"2","key":"3026_CR24","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/ajmg.a.61968","volume":"185","author":"G Pemmasani","year":"2021","unstructured":"Pemmasani G, Yandrapalli S. Age-stratified prevalence of relevant comorbidities and etiologies for hospitalizations in Prader\u2013Willi syndrome patients. Am J Med Genet A. 2021;185(2):600\u20131.","journal-title":"Am J Med Genet A"},{"key":"3026_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2023.1183525","volume":"14","author":"LJ Rice","year":"2023","unstructured":"Rice LJ, Agu J, Carter CS, Harris JC, Nazarloo HP, Naanai H, et al. The relationship between endogenous oxytocin and vasopressin levels and the Prader\u2013Willi syndrome behaviour phenotype. Front Endocrinol (Lausanne). 2023;14:1\u201315.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"14","key":"3026_CR26","doi-asserted-by":"publisher","first-page":"4033","DOI":"10.3390\/jcm11144033","volume":"11","author":"AGW Rosenberg","year":"2022","unstructured":"Rosenberg AGW, Wellink CM, Tellez Garcia JM, Pellikaan K, Van Abswoude DH, Davidse K, et al. Health problems in adults with Prader\u2013Willi syndrome of different genetic subtypes: cohort study, meta-analysis and review of the literature. J Clin Med. 2022;11(14):4033.","journal-title":"J Clin Med"},{"key":"3026_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.eurpsy.2017.03.007","volume":"44","author":"L Shriki-Tal","year":"2017","unstructured":"Shriki-Tal L, Avrahamy H, Pollak Y, Gross-Tsur V, Genstil L, Hirsch HJ, et al. Psychiatric disorders in a cohort of individuals with Prader\u2013Willi syndrome. Eur Psychiatry. 2017;44:47\u201352.","journal-title":"Eur Psychiatry"},{"issue":"10","key":"3026_CR28","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1017\/S0033291707002504","volume":"38","author":"S Soni","year":"2008","unstructured":"Soni S, Whittington J, Holland AJ, Webb T, Maina EN, Boer H, et al. The phenomenology and diagnosis of psychiatric illness in people with Prader\u2013Willi syndrome. Psychol Med. 2008;38(10):1505\u201314.","journal-title":"Psychol Med"},{"issue":"5","key":"3026_CR29","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/ajmg.a.36998","volume":"167","author":"ST Lo","year":"2015","unstructured":"Lo ST, Collin PJL, Hokken-Koelega ACS. Psychiatric disorders in children with Prader\u2013Willi syndrome-results of a 2-year longitudinal study. Am J Med Genet A. 2015;167(5):983\u201391.","journal-title":"Am J Med Genet A"},{"issue":"2","key":"3026_CR30","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/jir.12707","volume":"64","author":"SM Feighan","year":"2020","unstructured":"Feighan SM, Hughes M, Maunder K, Roche E, Gallagher L. A profile of mental health and behaviour in Prader\u2013Willi syndrome. J Intellect Disabil Res. 2020;64(2):158\u201369.","journal-title":"J Intellect Disabil Res"},{"issue":"11","key":"3026_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/genes11111250","volume":"11","author":"AS Montes","year":"2020","unstructured":"Montes AS, Osann KE, Gold JA, Tamura RN, Driscoll DJ, Butler MG, et al. Genetic subtype-phenotype analysis of growth hormone treatment on psychiatric behavior in Prader\u2013Willi syndrome. Genes (Basel). 2020;11(11):1\u201311.","journal-title":"Genes (Basel)"},{"key":"3026_CR32","first-page":"171S","volume":"17","author":"WMA Verhoeven","year":"2002","unstructured":"Verhoeven WMA, Curfs LMG, Tuinier S. Prader\u2013Willi syndrome and atypical psychoses. Int Rev Neurobiol. 2002;17:171S-171S.","journal-title":"Int Rev Neurobiol"},{"issue":"10","key":"3026_CR33","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.40.10.e112","volume":"40","author":"WMA Verhoeven","year":"2003","unstructured":"Verhoeven WMA, Tuinier S, Curfs LMG. Prader\u2013Willi syndrome: the psychopathological phenotype in uniparental disomy. J Med Genet. 2003b;40(10): e112.","journal-title":"J Med Genet"},{"issue":"5","key":"3026_CR34","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1159\/000106313","volume":"40","author":"WMA Verhoeven","year":"2007","unstructured":"Verhoeven WMA, de Vries BBA, Duffels SJH, Egger JIM, Noordam C, Tuinier S. Klinefelter\u2019s syndrome and Prader\u2013Willi syndrome: a rare combination. Psychopathology. 2007;40(5):356\u201360.","journal-title":"Psychopathology"},{"issue":"Pt 6","key":"3026_CR35","first-page":"455","volume":"42","author":"WMA Verhoeven","year":"1998","unstructured":"Verhoeven WMA, Curfs LM, Tuinier S. Prader\u2013Willi syndrome and cycloid psychoses. J Intell Disabil Res. 1998;42(Pt 6):455\u201362.","journal-title":"J Intell Disabil Res"},{"issue":"4","key":"3026_CR36","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1601-5215.2007.00202.x","volume":"19","author":"W Verhoeven","year":"2007","unstructured":"Verhoeven W, Egger J, Tuinier S. Thoughts on the behavioural phenotypes in Prader\u2013Willi syndrome and velo-cardio-facial syndrome: a novel approach. Acta Neuropsychiatrica. 2007;19(4):244\u201350.","journal-title":"Acta Neuropsychiatrica"},{"key":"3026_CR37","first-page":"34","volume":"7","author":"D Singh","year":"2019","unstructured":"Singh D, Sasson A, Rusciano V, Wakimoto Y, Pinkhasov A, Angulo M. Cycloid psychosis comorbid with Prader\u2013Willi syndrome: a case series. Am J Med Genet A. 2019;7:34.","journal-title":"Am J Med Genet A"},{"key":"3026_CR38","doi-asserted-by":"publisher","first-page":"497","DOI":"10.9758\/cpn.2018.16.4.497","volume":"16","author":"W Briegel","year":"2018","unstructured":"Briegel W. Clinical usefulness of aripiprazole treatment in a girl with Prader\u2013Willi syndrome and psychosis. Clin Psychopharmacol Neurosci. 2018;16:497.","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"11","key":"3026_CR39","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.1210\/jc.2016-2594","volume":"101","author":"RJ Kuppens","year":"2016","unstructured":"Kuppens RJ, Bakker NE, Siemensma EPC, Tummers-de Lind van Wijngaarden RFA, Donze SH, Festen DAM, et al. Beneficial effects of GH in young adults with Prader\u2013Willi syndrome: a 2-year crossover trial. J Clin Endocrinol Metab. 2016;101(11):4110\u20136. https:\/\/doi.org\/10.1210\/jc.2016-2594.","journal-title":"J Clin Endocrinol Metab"},{"key":"3026_CR40","first-page":"13","volume":"2015","author":"HM Poser","year":"2015","unstructured":"Poser HM, Trutia AE, Report C. Treatment of a Prader\u2013Willi patient with recurrent catatonia. Case Rep. 2015;2015:13.","journal-title":"Case Rep"},{"issue":"5","key":"3026_CR41","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.ridd.2011.02.027","volume":"32","author":"M Sinnema","year":"2011","unstructured":"Sinnema M, Boer H, Collin P, Maaskant MA, van Roozendaal KEP, Schrander-Stumpel CTRM, et al. Psychiatric illness in a cohort of adults with Prader\u2013Willi syndrome. Res Dev Disabil. 2011;32(5):1729\u201335.","journal-title":"Res Dev Disabil"},{"issue":"1","key":"3026_CR42","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1016-3190(10)60035-3","volume":"22","author":"P-N Chiou","year":"2010","unstructured":"Chiou P-N, Tsai L-P. Psychopharmacological treatment of Prader\u2013Willi syndrome. Tzu Chi Med J. 2010;22(1):43\u20136.","journal-title":"Tzu Chi Med J"},{"issue":"8","key":"3026_CR43","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1097\/chi.0b013e318068fbed","volume":"46","author":"S Herg\u00fcner","year":"2007","unstructured":"Herg\u00fcner S, Mukaddes NM. Psychosis associated with fluoxetine in Prader\u2013Willi syndrome. J Am Acad Child Adolesc Psychiatry. 2007;46(8):944\u20135.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"3026_CR44","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/ajmg.a.30004","volume":"127A","author":"A Vogels","year":"2004","unstructured":"Vogels A, De Hert M, Descheemaeker MJ, Govers V, Devriendt K, Legius E, et al. Psychotic disorders in Prader\u2013Willi syndrome. Am J Med Genet A. 2004;127A(3):238\u201343.","journal-title":"Am J Med Genet A"},{"issue":"1","key":"3026_CR45","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/00041444-199700710-00007","volume":"7","author":"H Watanabe","year":"1997","unstructured":"Watanabe H, Ohmori O, Abe K. Recurrent brief depression in Prader\u2013Willi syndrome: a case report. Psychiatr Genet. 1997;7(1):12.","journal-title":"Psychiatr Genet"},{"issue":"Pt 3","key":"3026_CR46","first-page":"235","volume":"33","author":"MS Bhate","year":"1989","unstructured":"Bhate MS, Robertson PE, Davison EV, Brummitt JA. Prader Willi syndrome with hypothyroidism. J Ment Defic Res. 1989;33(Pt 3):235\u201344.","journal-title":"J Ment Defic Res"},{"issue":"02","key":"3026_CR47","doi-asserted-by":"publisher","first-page":"54","DOI":"10.21926\/obm.neurobiol.2002054","volume":"04","author":"R Sweeney","year":"2020","unstructured":"Sweeney R, La Rosa AJ, Sheade N, Olson-Marszewski RC, Bergren R, Meresh E. Catatonia following cessation of topiramate in a patient with Prader\u2013Willi syndrome: case report and review of literature. OBM Neurobiol. 2020;04(02):54. https:\/\/doi.org\/10.21926\/obm.neurobiol.2002054.","journal-title":"OBM Neurobiol."},{"issue":"3","key":"3026_CR48","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.psym.2018.07.014","volume":"60","author":"S Zwiebel","year":"2019","unstructured":"Zwiebel S, Rayapati AO, de Leon J. Catatonia following abrupt cessation of oxcarbazepine in a patient with Prader\u2013Willi syndrome. Psychosomatics. 2019;60(3):311\u20135.","journal-title":"Psychosomatics"},{"key":"3026_CR49","first-page":"24","volume":"8","author":"R Jacob","year":"2009","unstructured":"Jacob R, Chowdhury A, Kamath S, Ganesan J. Psychiatric comorbidity in Prader\u2013Willi syndrome a case series. German J Psychiatry. 2009;8:24.","journal-title":"German J Psychiatry."},{"issue":"2","key":"3026_CR50","first-page":"79","volume":"4","author":"J Takhar","year":"1997","unstructured":"Takhar J, Malla AK. Clozapine therapy for psychosis and Parkinsonism in a phenotypical case of Prader\u2013Willi syndrome. Can J Clin Pharmacol. 1997;4(2):79\u201381.","journal-title":"Can J Clin Pharmacol"},{"issue":"3","key":"3026_CR51","first-page":"275","volume":"8","author":"P Tyndall","year":"1997","unstructured":"Tyndall P, Fitzpatrick C. Psychotic episode in an adolescent with Prader\u2013Willi syndrome: a case report. Genet Couns. 1997;8(3):275.","journal-title":"Genet Couns"},{"issue":"6","key":"3026_CR52","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/j.1365-2788.1994.tb00463.x","volume":"38","author":"G Bartolucci","year":"1994","unstructured":"Bartolucci G, Younger J. Tentative classification of neuropsychiatric disturbances in Parader-Willi syndrome. J Intell Disabil Res. 1994;38(6):621\u20139.","journal-title":"J Intell Disabil Res"},{"issue":"1","key":"3026_CR53","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/ajmg.a.38525","volume":"176","author":"D Thuilleaux","year":"2018","unstructured":"Thuilleaux D, Laurier V, Copet P, Tricot J, Demeer G, Mourre F, et al. A model to characterize psychopathological features in adults with Prader\u2013Willi syndrome. Am J Med Genet A. 2018;176(1):41\u20137. https:\/\/doi.org\/10.1002\/ajmg.a.38525.","journal-title":"Am J Med Genet A"},{"issue":"11","key":"3026_CR54","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1017\/S0033291713002961","volume":"44","author":"FV Larson","year":"2014","unstructured":"Larson FV, Whittington J, Webb T, Holland AJ. A longitudinal follow-up study of people with Prader\u2013Willi syndrome with psychosis and those at increased risk of developing psychosis due to genetic subtype. Psychol Med. 2014;44(11):2431\u20135.","journal-title":"Psychol Med"},{"issue":"7","key":"3026_CR55","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/ajmg.a.32212","volume":"146A","author":"T Webb","year":"2008","unstructured":"Webb T, Maina EN, Soni S, Whittington J, Boer H, Clarke D, et al. In search of the psychosis gene in people with Prader\u2013Willi syndrome. Am J Med Genet A. 2008;146A(7):843\u201353.","journal-title":"Am J Med Genet A"},{"issue":"Pt 1","key":"3026_CR56","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1365-2788.2006.00895.x","volume":"51","author":"S Soni","year":"2007","unstructured":"Soni S, Whittington J, Holland AJ, Webb T, Maina E, Boer H, et al. The course and outcome of psychiatric illness in people with Prader\u2013Willi syndrome: implications for management and treatment. J Intellect Disabil Res. 2007;51(Pt 1):32\u201342.","journal-title":"J Intellect Disabil Res"},{"issue":"6","key":"3026_CR57","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s00787-020-01568-7","volume":"30","author":"M Krefft","year":"2021","unstructured":"Krefft M, Frydecka D, Zalsman G, Krzystek-Korpacka M, \u015amigiel R, G\u0119bura K, et al. A pro-inflammatory phenotype is associated with behavioural traits in children with Prader\u2013Willi syndrome. Eur Child Adolesc Psychiatry. 2021;30(6):899\u2013908. https:\/\/doi.org\/10.1007\/s00787-020-01568-7.","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"3026_CR58","doi-asserted-by":"publisher","first-page":"580503","DOI":"10.3389\/fpsyt.2020.580503","volume":"11","author":"A Kocsis","year":"2020","unstructured":"Kocsis A, Gajwani R, Gross J, Gumley AI, Lawrie SM, Schwannauer M, et al. Altered autonomic function in individuals at clinical high risk for psychosis. Front Psychiatry. 2020;11:580503.","journal-title":"Front Psychiatry."},{"issue":"4","key":"3026_CR59","first-page":"73","volume":"59","author":"AJ Frances","year":"1998","unstructured":"Frances AJ, Kahn DA, Carpenter D, Docherty JP, Donovan SL. The expert consensus guidelines for treating depression in bipolar disorder. J Clin Psychiatry. 1998;59(4):73\u20139.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"3026_CR60","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1192\/bjp.2017.7","volume":"212","author":"R Krishnadas","year":"2018","unstructured":"Krishnadas R, Cooper SA, Nicol A, Pimlott S, Soni S, Holland AJ, et al. Brain-stem serotonin transporter availability in maternal uniparental disomy and deletion Prader\u2013Willi syndrome. Br J Psychiatry. 2018;212(1):57\u20138.","journal-title":"Br J Psychiatry"},{"issue":"10","key":"3026_CR61","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1210\/endo.141.10.7731","volume":"141","author":"ND \u00c4berg","year":"2000","unstructured":"\u00c4berg ND, Carlsson B, Rosengren L, Oscarsson J, Isaksson OGP, R\u00f6nnb\u00e4ck L, et al. Growth hormone increases connexin-43 expression in the cerebral cortex and hypothalamus. Endocrinology. 2000;141(10):3879\u201386.","journal-title":"Endocrinology"},{"issue":"1","key":"3026_CR62","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00431-015-2670-x","volume":"175","author":"O Bonnot","year":"2016","unstructured":"Bonnot O, Cohen D, Thuilleaux D, Consoli A, Cabal S, Tauber M. Psychotropic treatments in Prader\u2013Willi syndrome: a critical review of published literature. Eur J Pediatr. 2016;175(1):9\u201318.","journal-title":"Eur J Pediatr"},{"issue":"3","key":"3026_CR63","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s11920-007-0017-7","volume":"9","author":"V Peralta","year":"2007","unstructured":"Peralta V, Cuesta MJ, Zandio M. Cycloid psychosis: an examination of the validity of the concept. Curr Psychiatry Rep. 2007;9(3):184\u201392. https:\/\/doi.org\/10.1007\/s11920-007-0017-7.","journal-title":"Curr Psychiatry Rep"},{"key":"3026_CR64","unstructured":"Perris C, Brockington IF, Struwe D, Janson B. Biological psychiatry.\u00a01981."}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03026-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-024-03026-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03026-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T11:07:38Z","timestamp":1707995258000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-024-03026-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,15]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3026"],"URL":"https:\/\/doi.org\/10.1186\/s13023-024-03026-y","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,15]]},"assertion":[{"value":"2 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"69"}}